#ASND

News 📈 Stocks

Ascendis Pharma Regains TransCon Rights After Novo Nordisk Collaboration Ends

September 19, 2026 (52 days ago)

Ascendis Pharma reclaims full control of its TransCon metabolic pipeline from Novo Nordisk, trading partnership security for the potential to capture higher…

ASND NVO

🌍 EUROPE Read More →

News 📈 Stocks

BioMarin and Ascendis Resolve Patent Dispute, Shares Rally 5% on Settlement

September 12, 2026 (59 days ago)

BioMarin and Ascendis settle a global patent dispute over the drug Yuviwel, with BioMarin securing a 20% US royalty stream and Ascendis…

BMRN ASND

🌍 GLOBAL Read More →